A study to evaluate the effect of ceralasertib on Drug X, Drug Y and Drug Z

Trial Identifier:	D533BC00003
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	May 2025
Primary Completion Date:	November 2025
Study Completion Date:	March 2026
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
ES	Barcelona, ES, 08023
ES	Madrid, ES, 28050
ES	Madrid, ES, 28040
GB	Manchester, GB, M20 4BX

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.